UltraShape is a leading developer, manufacturer and marketer of innovative, non-invasive solutions for the aesthetic medical field. By applying its singular ultrasound know-how, UltraShape’s professionals and scientists have developed the first clinically proven body contouring solution that combines totally non-invasive treatment with durable measurable results – an achievement that places UltraShape in the forefront of body contouring technology.
The UltraShape solution is a safe and simple, "walk-in, walk-out" office based procedure. The company’s patented technology is based on the application of focused therapeutic ultrasound that selectively targets and disrupts fat cells without damaging neighboring structures. To date, more than 30,000 UltraShape procedures have been dispensed in over 250 clinics in 46 countries worldwide.
The concept behind the company’s technology was developed by plastic surgeon Ami Glicksman, M.D., and medical physicist Yoram Eshel, Ph.D., MBA, who merged their aesthetic clinical experience with expertise in high power focused ultrasound.
UltraShape is dedicated to providing healthcare professionals with leading edge solutions that enhance the lives of patients worldwide. In June 2005, UltraShape received CE mark approval and launched its first product, the Contour I system. In May 2007, UltraShape launched the Contour I ver. 2 system, the latest in body contouring technology featuring new software system and new illumination.
Founded in 2000, UltraShape is a privately held and venture backed company with offices in the United States, Israel, France, United Kingdom and Italy.

 Rosslyn Medical exclusively presents UltraShape on Russian market.

www.ultrashape.com/ru